Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Boslego

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Vaccine|March 1, 1985
Pilus vaccinesE C Tramont, J W Boslego
Advances in Experimental Medicine and Biology|January 1, 1987
Pathogenesis and management of gonorrheaE C Tramont, J W Boslego
Journal of Immunological Methods|January 1, 1981
A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodiesW D Zollinger, J W Boslego
The Journal of Infectious Diseases|June 1, 1987
Evidence of serum antibodies to Neisseria gonorrhoeae before gonococcal infectionC B Hicks, J W Boslego, B Brandt
Antimicrobial Agents and Chemotherapy|May 1, 1988
Spectinomycin disk zone diameter as a predictor of outcome in clinical treatment of gonorrheaD G McChesney, J W Boslego, W N Khan
Infection and Immunity|June 1, 1982
Genital antibody response to a parenteral gonococcal pilus vaccineD McChesney, E C Tramont, J W Boslego, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1992
Antibiotic susceptibility survey of Neisseria gonorrhoeae in ThailandT E Clendennen, P Echeverria, S Saengeur, et al.
Epidemiology and Infection|April 11, 2001
The effectiveness of Haemophilus influenzae type b conjugate vaccines in a high risk population measured using immunization register dataP Markey, V Krause, J W Boslego, et al.
Pharmaceutical Biotechnology|January 1, 1995
Public health implications of emerging vaccine technologiesD N Lawrence, K L Goldenthal, J W Boslego, et al.
The Journal of Experimental Medicine|December 1, 1991
Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in menH Schneider, J M Griffiss, J W Boslego, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Vaccine|March 1, 1985
Pilus vaccinesE C Tramont, J W Boslego
Advances in Experimental Medicine and Biology|January 1, 1987
Pathogenesis and management of gonorrheaE C Tramont, J W Boslego
Journal of Immunological Methods|January 1, 1981
A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodiesW D Zollinger, J W Boslego
The Journal of Infectious Diseases|June 1, 1987
Evidence of serum antibodies to Neisseria gonorrhoeae before gonococcal infectionC B Hicks, J W Boslego, B Brandt
Antimicrobial Agents and Chemotherapy|May 1, 1988
Spectinomycin disk zone diameter as a predictor of outcome in clinical treatment of gonorrheaD G McChesney, J W Boslego, W N Khan
Infection and Immunity|June 1, 1982
Genital antibody response to a parenteral gonococcal pilus vaccineD McChesney, E C Tramont, J W Boslego, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1992
Antibiotic susceptibility survey of Neisseria gonorrhoeae in ThailandT E Clendennen, P Echeverria, S Saengeur, et al.
Epidemiology and Infection|April 11, 2001
The effectiveness of Haemophilus influenzae type b conjugate vaccines in a high risk population measured using immunization register dataP Markey, V Krause, J W Boslego, et al.
Pharmaceutical Biotechnology|January 1, 1995
Public health implications of emerging vaccine technologiesD N Lawrence, K L Goldenthal, J W Boslego, et al.
The Journal of Experimental Medicine|December 1, 1991
Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in menH Schneider, J M Griffiss, J W Boslego, et al.
Pageof 2